Genomix Co. raises 1 billion Yen by 3d party allotment

The company is engaged in R&D that promotes healing and regeneration of injured tissue by activating bone marrow-derived stem cells and accumulating them in the affected area via circulation of peripheral blood.


Request a quote for deeper information from

© 2018 Window to Japan - Bio 4 Business - Imprint